Global TCR-Based Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global TCR-Based Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
TCR-Based Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TCR-Based Antibody market is projected to reach US$ 1787.4 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 9.8% during the period of 2024 to 2029. Demand from Hospitals and Specialized Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TCR-Based Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, TCR-Based Antibody key manufacturers include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. Adaptimmune Therapeutics, Celgene, Immunocore are top 3 players and held % sales share in total in 2022.
TCR-Based Antibody can be divided into NY-ESO-1, p53, WT-1 and EBv, etc. NY-ESO-1 is the mainstream product in the market, accounting for % sales share globally in 2022.
TCR-Based Antibody is widely used in various fields, such as Hospitals, Specialized Clinics, Pharma and Biotech Research Laboratories. and Gene Therapy Centers, etc. Hospitals provides greatest supports to the TCR-Based Antibody industry development. In 2022, global % sales of TCR-Based Antibody went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TCR-Based Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Adaptimmune Therapeutics
Celgene
Immunocore
Kuur Therapeutics
Lion TCR
Kite Pharma
Takara Bio
Ziopharm Oncology
GlaxoSmithKline
Merck
Juno Theraprutics
Segment by Type
NY-ESO-1
p53
WT-1
EBv
Others
Hospitals
Specialized Clinics
Pharma and Biotech Research Laboratories.
Gene Therapy Centers
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the TCR-Based Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TCR-Based Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TCR-Based Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of TCR-Based Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TCR-Based Antibody introduction, etc. TCR-Based Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of TCR-Based Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
TCR-Based Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TCR-Based Antibody market is projected to reach US$ 1787.4 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 9.8% during the period of 2024 to 2029. Demand from Hospitals and Specialized Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TCR-Based Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, TCR-Based Antibody key manufacturers include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. Adaptimmune Therapeutics, Celgene, Immunocore are top 3 players and held % sales share in total in 2022.
TCR-Based Antibody can be divided into NY-ESO-1, p53, WT-1 and EBv, etc. NY-ESO-1 is the mainstream product in the market, accounting for % sales share globally in 2022.
TCR-Based Antibody is widely used in various fields, such as Hospitals, Specialized Clinics, Pharma and Biotech Research Laboratories. and Gene Therapy Centers, etc. Hospitals provides greatest supports to the TCR-Based Antibody industry development. In 2022, global % sales of TCR-Based Antibody went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TCR-Based Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Adaptimmune Therapeutics
Celgene
Immunocore
Kuur Therapeutics
Lion TCR
Kite Pharma
Takara Bio
Ziopharm Oncology
GlaxoSmithKline
Merck
Juno Theraprutics
Segment by Type
NY-ESO-1
p53
WT-1
EBv
Others
Segment by Application
Hospitals
Specialized Clinics
Pharma and Biotech Research Laboratories.
Gene Therapy Centers
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the TCR-Based Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TCR-Based Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TCR-Based Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of TCR-Based Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TCR-Based Antibody introduction, etc. TCR-Based Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of TCR-Based Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices